Baird Financial Group
PRCT icon

Baird Financial Group’s Procept Biorobotics PRCT Stock Holding History

Baird Financial Group’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-70,117
Closed -$4.09M – 1841
2025
Q1 		$4.09M Buy
70,117
+15,880
+29% +$1.08M 0.01% 747
2024
Q4 		$4.37M Buy
54,237
+15,327
+39% +$1.31M 0.01% 713
2024
Q3 		$3.12M Sell
38,910
-6,599
-15% -$469K 0.01% 827
2024
Q2 		$2.78M Buy
+45,509
New +$2.71M 0.01% 864

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Baird Financial Group's PRCT Position: Q2 2025 in Review

Baird Financial Group sold out of Procept Biorobotics (PRCT) in Q2 2025, closing a stake of 70,117 shares — an estimated $4.09M sold.

Baird Financial Group first reported a position in PRCT in Q2 2024 and held it in 4 quarters. The position peaked at $4.37M in Q4 2024. 271 funds tracked by Wall St. Rank hold PRCT as of Q2 2025.

  • Baird Financial Group reported no remaining Procept Biorobotics position as of Q2 2025 after selling out during the quarter.
  • Baird Financial Group sold 70,117 Procept Biorobotics shares in Q2 2025, an estimated $4.09M.
  • Baird Financial Group first reported a position in Procept Biorobotics in Q2 2024 and held it in 4 quarters.
  • Baird Financial Group's Procept Biorobotics position peaked at $4.37M in Q4 2024.
  • 271 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2025.

Based on Baird Financial Group's 13F filing for Q2 2025, filed 13 Aug 2025.